Author: Nwokolo C.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.21, Iss.8, 2001-08, pp. : 537-544
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hydroxycarbamide holds up to long-term scrutiny in sickle cell anaemia
Inpharma, Vol. 1, Iss. 1275, 2001-01 ,pp. :
Sickle Cell Anaemia: Epidemiology and Cost of Illness
By Nietert P.J.
PharmacoEconomics, Vol. 20, Iss. 6, 2002-06 ,pp. :
Stroke in Children With Sickle Cell Anaemia: Aetiology and Treatment
By Pegelow C.H.
Pediatric Drugs, Vol. 3, Iss. 6, 2001-01 ,pp. :
Hydroxycarbamide well tolerated in paediatric sickle cell anaemia
Inpharma, Vol. 1, Iss. 1326, 2002-01 ,pp. :
Sickle Cell Anaemia: Progress in Pathogenesis and Treatment
By Ballas S.K.
Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. :